-
effectivehealthcare.ahrq.gov/sites/default/files/methods-guide_prepublication-draft_03-2011.pdf
January 01, 2011 - Tools to help you prepare to talk with your clinician about treatment … Download our research summaries about the risks and benefits of different treatments for health conditions … Open for comment until Aug. 10, 2017
Harms of First-Line Depression Treatment … Supplemental Project To Assess the Transparency of Reporting for Trials Evaluating Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/mrsascreening_protocol_20110602.pdf
August 10, 2017 - Tools to help you prepare to talk with your clinician about treatment … Download our research summaries about the risks and benefits of different treatments for health conditions … Open for comment until Aug. 10, 2017
Harms of First-Line Depression Treatment … Supplemental Project To Assess the Transparency of Reporting for Trials Evaluating Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/20090427identtifyingtopics.pdf
August 10, 2017 - Tools to help you prepare to talk with your clinician about treatment … Download our research summaries about the risks and benefits of different treatments for health conditions … Open for comment until Aug. 10, 2017
Harms of First-Line Depression Treatment … Supplemental Project To Assess the Transparency of Reporting for Trials Evaluating Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/decision-models-guidance-160915.pdf
August 10, 2017 - Tools to help you prepare to talk with your clinician about treatment … Download our research summaries about the risks and benefits of different treatments for health conditions … Open for comment until Aug. 10, 2017
Harms of First-Line Depression Treatment … Supplemental Project To Assess the Transparency of Reporting for Trials Evaluating Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/module-i-ahrqs-vision-for-theory-and-principles-of-stakeholder-engagement.pdf
August 10, 2017 - Tools to help you prepare to talk with your clinician about treatment … Download our research summaries about the risks and benefits of different treatments for health conditions … Open for comment until Aug. 10, 2017
Harms of First-Line Depression Treatment … Supplemental Project To Assess the Transparency of Reporting for Trials Evaluating Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/25th-anniversary-epc-brochure.pdf
November 01, 2022 - has produced more than 800 reports that reviewed and evaluated the
evidence on topics ranging from treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diverticulitis-research-protocol.pdf
January 01, 2019 - diverticulitis revealed unproven differences in outcomes
between observational management and antibiotic therapy … Various pharmacologic treatments are used in clinical
practice, although uncertainty remains. … Analytic Framework for Key Question 4: Treatments to prevent recurrent diverticulitis.
14 … Prevention and Conservative Therapy of Diverticular Disease. … Prospective randomized trial comparing short-term
antibiotic therapy versus standard therapy for acute
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
December 01, 2011 - , screening and diagnostics, therapeutics,
surgery, and care delivery innovations—which are referred … Potential to change current treatment models
b. … cardiovascular
medicine professionals; reports on
emerging technologies, techniques and
medical therapies … treatments. … administration[mh]
6 Organizational AND (“case studies” OR culture)
7 Combine
sets
#5 OR #6
8 New
therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
June 01, 2010 - Until these trials on the use of progesterone were published, no other generally effective therapy
had … issues such as optimal
route of drug delivery and long-term drug safety remain.13
FDA Approved Treatments … No treatments approved by the Food and Drug Administration (FDA) for the prevention of
preterm birth … other important outcomes,
including unanticipated harms
Maternal outcomes:
• Adverse effects of therapy … of therapy remote from pregnancy
Timing
Progestogen after the first trimester through childhood
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_disposition-comments.pdf
October 05, 2010 - There are two
studies (#168, and #145) comparing nonoperative
treatments. … The sentence has been revised as follows (page 104): “One RCT
evaluated individualized physical therapy … Can the authors provide
recommendations for how to select a therapy, even in the
absence of firm evidence … (1-4,8), the benefits and pitfalls of
nonoperative treatment (1-4,8), the early treatment of cuff … tears (5), and the benefits of surgical treatment vs. failed
non-op treatment (6,7).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
March 15, 2016 - I agree that potential discontinuation (“drug holiday”) of urate-lowering therapy after
effective treatment … also approved RA treatments). … Doherty M, Bardin T, et al; EULAR Standing Committee for International
Clinical Studies Including Therapeutics … Part 1: systematic nonpharmacologic and
pharmacologic therapeutic approaches to
hyperuricemia. … Given our experience
in this therapeutic area, we are submitting a comment to provide updates, since
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
December 27, 2016 - • KQ1a: No treatment (placebo or control) OR pharmacologic therapy which
includes controller therapy … KQ2a-b: ICS+LAMA controller therapy
KQ2c: ICS+LABA+LAMA controller therapy
Therapies considered … listed in the PICOTS
Comparator KQ1a: No treatment OR pharmacologic
therapy OR non-pharmacologic … Therapies are further defined according to
PICOTS above. … as
defined in PICOTS
KQ2c: ICS+LABA controller therapy
Therapies considered an ICS, LABA or
LAMA
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
December 16, 2011 - therapy, can occur during the first 2 years of treatment and sometimes many
years into treatment. … ; 1
= very good, 4 = unchanged or
worsened)
Side-effects (item 4; 1 = none, 4
= outweighs therapeutic … What are the benefits from RLS treatments when compared to placebo or no treatment?
b. … What are the harms from RLS treatments when compared to placebo or no treatment?
b. … Comparators
Placebo (or sham treatments), no treatment, or other active comparator
Outcomes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - It was
addressed as an outcome only for the balance,
exercise and physical therapy therapies. … Peer reviewer #1 General For nonpharmacologic treatment options, specific
types of therapeutic footwear … No
treatments improved quality of life (low SOE). … Bergman
General I am sorry to see that there was no evaluation of the
safety or effectiveness of topical … is worth
considering, especially for people on chronic opiate
therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - It was
addressed as an outcome only for the balance,
exercise and physical therapy therapies. … Peer reviewer #1 General For nonpharmacologic treatment options, specific
types of therapeutic footwear … No
treatments improved quality of life (low SOE). … Bergman
General I am sorry to see that there was no evaluation of the
safety or effectiveness of topical … is worth
considering, especially for people on chronic opiate
therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_executive.pdf
July 01, 2010 - What are the associated risks, adverse effects, and
potential harms of nonoperative and operative
therapies … versus physical
therapy alone. … Aquatic therapy with land-based therapy vs. … treatment
Shock-wave therapy vs. mini-open RCR (n=1) Low The evidence was too limited to make a conclusion … Physical therapy treatment, oral medication, Low The evidence was too limited to make a conclusion.
and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-screening_research-protocol.pdf
October 20, 2011 - response in relation to outcomes, such as adherence to treatment. … During
discussions with Key Informants, our interest in expanding the scope of HCV treatments arose … , and adherence to HCV antiviral therapy. … What proportion of patients with screen-detected HCV infection receives treatment? … d
Refers to eligibility for antiviral treatment based on viral and host factors.
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
December 01, 2015 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Unfortunately, these
challenges translate to slow progress in developing and validating new behavioral treatments … survey available outlets for information on novel interventions and new
applications of existing therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0488_12-27-2011.pdf
January 01, 2011 - Document Completion Date: 02-14-12
2
invasive testing (e.g., biopsies and surgery), unnecessary treatment … Accurate initial staging of
pancreatic cancer can improve decision-making about appropriate therapy,
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
December 01, 2015 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … This new formulation was added to the system in 2014 as a therapy in
late-stage development for treating … initiative to advance patient screening
timelines, automate diagnostic steps, and increase early treatment